Seattle Genetics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
62,520.00
76,141.00
120,486.00
140,111.00
125,530.00
222,693
Depreciation, Depletion & Amortization
8,615.00
12,490.00
14,505.00
18,034.00
24,269.00
26,032
Other Funds
32,683.00
39,735.00
43,761.00
56,335.00
2,989.00
70,676
Funds from Operations
21,222.00
23,916.00
62,220.00
65,742.00
104,250.00
149,638
Changes in Working Capital
20,112.00
36,083.00
70,983.00
31,229.00
14,650.00
53,898
Net Operating Cash Flow
1,110.00
59,999.00
133,203.00
96,971.00
118,900.00
203,536
Capital Expenditures
22,154.00
17,176.00
13,392.00
27,835.00
28,722.00
Purchase/Sale of Investments
2,482.00
53,798.00
362,458.00
96,028.00
200,240.00
Net Investing Cash Flow
24,636.00
36,622.00
375,850.00
68,193.00
129,861.00
Net Financing Cash Flow
35,199.00
16,188.00
554,381.00
35,196.00
41,311.00
Net Change in Cash
9,453.00
7,189.00
45,328.00
6,418.00
52,272.00
Free Cash Flow
23,264.00
77,175.00
146,595.00
124,806.00
147,622.00
Net Assets from Acquisitions
-
-
-
-
41,657.00
Change in Capital Stock
35,199.00
16,188.00
554,381.00
35,196.00
41,311.00
About Seattle Genetics
View Profile
